Background: Tumor-associated macrophages (TAMs) are important determinants of intratumoral immune evasion, neoangiogenesis, extracellular matrix remodeling and dysregulated tumor cell proliferation. Our prior studies revealed that macrophage-derived, but not tumor cell-derived, macrophage migration inhibitory factor (MIF), is an important determinant of TAM alternative activation and M2 polarization. Aim: Because MIF is historically thought to initiate signaling via a receptor-dependent, outside-in mode of action, we wished to investigate the specific contributions of tumor-derived vs. macrophage-derived MIF to M2 marker expression during macrophage polarization. Design: Murine oral squamous cell-carcinoma cells (SCCVII) were co-cultured with either the RAW 264.7 mouse macrophage cell line or mouse primary bone marrow-derived macrophages in the context of MIF genetic loss/inhibition individually or in combination each cell type. Methods: Twelve well Transwell plates were used to co-culture SCCVII cells and RAW 264.7, MIF þ/þ or MIF À/À macrophages
Introduction
Inflammation promotes nearly all stages of solid cancer carcinogenesis and tumor progression. 1 Cancer-associated inflammation, including the infiltration of tumor-associated macrophages (TAMs), regulates tumor growth and progression in a variety of ways depending on the type and frequency of released tumorderived factors. 2, 3 These factors, in turn, dictate whether infiltrating TAM phenotypes are pro-or antitumorigenic. 3 The cytokine macrophage migration inhibitory factor (MIF) is induced by a variety of stimuli in monocytes and macrophages and has been shown to play an important functional role in innate immune tumor responses. [4] [5] [6] Prior studies demonstrated that macrophagederived MIF enables tumor stromal macrophages to be maximally polarized to an immunosuppressive, pro-tumorigenic phenotype. 7 Oral squamous cell carcinoma (OSCC) is the most prevalent among head and neck neoplasms. Etiological factors contributing to these cancers include smoking and alcohol consumption which make up primary risk factors in more than 80% of these malignancies. 8 In 2012, there were an estimated 300 000 new cases of oral cancer representing 2.1% of the world's total cancer cases. 9 The 5-year survival rate for oral cancer remains $50% mostly due to the late stage of diagnosis. The last global cancer statistics estimated that 145 000 deaths/year occur in OSCC patients with 77% of these deaths occurring in less developed countries. 10 Importantly, TAM infiltration and functional activation is an important prognostic indicator of OSCC lymphangiogenesis, metastatic dissemination and overall survival. 11, 12 The present study aimed to investigate whether OSCC cells induce macrophage polarization and whether MIF participates in those responses. Methods: bone marrow-derived cells were isolated from the bone-marrow of C57Bl/6 MIF þ/þ and MIF À/À mice and differentiation into mature macrophages by macrophage colony stimulating factor (M-CSF). After differentiation, the bone marrow-derived macrophages (BMDMs) or the murine macrophage cell line RAW 264.7, were co-cultured with the murine OSCC cell line SCCVII, followed by assessment of the expression of macrophage activation markers by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting. mRNA expression data are given in relative quantity and analyzed by Student's T parametric test. Statistical significance was adopted as P < 0.05. 
Materials and methods

Cell lines
The murine macrophage cell line, RAW 264. 
In vitro generation of murine BMDMu
Bone marrow cells were extracted from femurs and tibias of C57BL/6 mice and red blood cells were lysed using 1Â RBC lysis buffer solution (eBioscience V R , #00-433-57); 4Â10 6 bone marrow cells re-suspended in 10 ml of RPMI 10% FCS containing 25 ng/ml of murine recombinant M-CSF were plated in 10 cm 2 petri dishes and cultured for a total of 7 days. Four days after plating, spent media was replaced with fresh RPMI/FCS/M-CSF for the remaining 3 days.
Treatments and co-culture In some experiments, 10 ng/ml of interleukin 4 (IL-4) was added to the macrophages in the lower chamber as indicated. Cocultures were incubated for 48 h followed by macrophage lysis and assessment by qRT-PCR or western blotting.
Real time quantitative PCR (qRT-PCR)
Total RNA was extracted using the RNeasy mini kit V R (Qiagen, CA, USA; #74104) and including a genomic DNA digestion step using RNAse-free DNase (Qiagen; #79254 
Western blotting
Cells were lysed in RIPA buffer (1:10, ThermoFisher Scientific; #89900) and the protein quantification assay was carried out using the DC Protein Assay Kit (Bio-Rad, CA, USA; #500-0112) according to the manufacturer's instructions. Equal protein amounts were electrophoresed, transferred to PVDF membranes and then blocked in a blocking buffer composed of TRIS 1 M pH 7.5, NaCl 5 M, Tween 20, goat serum, distilled water and non-fat dry milk. Membranes were probed in the same blocking buffer with anti-arginase 1 primary antibody (E-2; Santa Cruz Biotechnology V R ; #sc-271430), anti-GAPDH primary antibody (14C10, Cell Signaling Technology V R , MA, USA; #2118) or anti-MIF primary antibody (TP234, Torrey Pines Biolabs) and chemiluminescent development was performed with Pierce ECL Western Blotting Substrate (ThermoFisher Scientific; #32106). Western blotting normalization was made using Image Lab Software 5.2.1 (Bio-Rad).
Statistical analyses
The software GraphPad Prism 7.0c (GraphPad Prism Software, Inc., CA, USA) was used for statistical analyses. Comparisons between groups were performed using the two-tailed Student's T parametric test. P values <0.05 were considered statistically significant for all the tests.
Results
Oral cancer cells promote RAW 264.7 macrophage activation/polarization in a density-dependent manner
It has been reported that oral cancers, like other solid tumors, are infiltrated by TAMs which acquire an M2 polarization phenotype and are commonly discerned by their cell surface expression of CD163 þ . 12 Intratumoral infiltration of TAMs is associated with increased immunosuppression, neo-angiogenesis, metastatic dissemination and reduced overall survival. [12] [13] [14] However, the precise phenotypic contribution of TAMs to OSCC disease progression and how these phenotypes are specifically regulated by malignant cell-derived factors are still poorly understood. To initially investigate whether macrophage phenotypes are influenced by OSCC soluble factors, we co-cultured RAW 264.7 murine macrophages with different densities of the murine OSCC line, SCCVII, 15 and determined whether there were any changes in macrophage mRNA expression levels of prototypical M2/M1 gene products: arginase 1 (Arg1), 16 VEGF-A, 17 Cox-2 18 and iNOS. 18 As shown in Figure 1 , SCCVII coculture increases mRNA expression of Arg1 ( Figure 1A ), VEGF-A ( Figure 1B ), Cox-2 ( Figure 1C ) and iNOS ( Figure 1D ). Importantly, treatment of macrophages with the small molecule MIF inhibitor 4-IPP 7, 19 results in a nearly complete attenuation of SCCVIIinduced expression of these gene products at the lower density SCCVII co-culture and slightly less inhibitory activity at the higher density co-culture ( Figure 1A-D) . Interestingly, while SCCVII cells were unable to significantly influence the expression of the prototypical M2 cell surface marker, CD206, 4-IPP treated macrophages cultured both alone and with SCCVII cells exhibited a modest increase in CD206 ( Figure 1E ).
OSCC-mediated RAW 264.7 macrophage activation requires macrophage-derived, but not tumor-derived, MIF
Prior studies from our laboratory demonstrated that monocyte/ macrophage-derived MIF is necessary for maximal melanomainduced intratumoral M2 TAM alternative activation-despite the fact that B16F1 and B16F10 melanoma cell lines utilized in these models express and secrete copious amounts of MIF. 7 Because MIF is expressed and secreted at high levels in many solid cancers and, in some cases, acts in a paracrine manner to directly influence pro-tumorigenic innate immune cell activation/ differentiation, [20] [21] [22] we sought to investigate what contributions, if
any, did tumor cell-derived MIF contribute to OSCC-induced macrophage activation. To accomplish this, we co-cultured vehicle or 4-IPP-treated RAW 264.7 macrophages (gray bars) with vehicle or 4-IPP-treated SCCVII cells (black bars). As shown in Figure 2 (and similar to results observed in Figure 1 ), MIF inhibition in RAW 264.7 cells consistently and significantly attenuated the SCCVII-induced expression of Arg1 (Figure 2A ), VEGF-A ( Figure 2B ), iNOS ( Figure 2D ) and reduced Cox-2 expression, albeit not significantly. In contrast, 4-IPP treatment of SCCVII cells has no significant impact on SCCVII-cell induced Arg1, VEGF-A, Cox-2 or iNOS expression. Lastly, although macrophage CD206 mRNA expression was, again, unaffected by SCCVII co-culture it was increased by macrophage 4-IPP inhibition that was nominally (albeit significantly) reduced by 4-IPP treated SCCVII cells ( Figure 2E ). To validate the specificity of MIF inhibition and observed activities by 4-IPP, we next generated a stable RAW 264.7 cell line expressing MIF shRNA and co-cultured with SCCVII cells. (Figures 1 and 2) . Moreover, the increase in CD206 mRNA observed with 4-IPP treatment is recapitulated in MIF shRNA-expressing RAW 264.7 macrophages cultured alone and with SCCVII cells (Figure 3E ).
OSCC co-culture synergizes with IL-4 in macrophage alternative activation IL-4 is a Th2 immune response modifier that is well-documented to induce M2 macrophage polarization. 23 We next investigated whether MIF is necessary for maximal IL-4-induced M2 macrophage polarization and whether SCCVII cell co-culture synergizes with it. We initially tested MIF inhibition by both 4-IPP ( Figure 4A and C) and MIF shRNA ( Figure 4B and D) in RAW 264.7 cells treated with and without IL-4 in the presence and absence of SCCVII co-culture.
As shown in Figure 4A and B, 4-IPP-treatment and MIF shRNA knockdown significantly reduces both individual IL-4-induced and SCCVII co-culture-induced Arg1 expression with the largest MIF contributions observed with SCCVII co-culture. Interestingly, IL-4/ SCCVII co-culture combination treatment dramatically increases Arg1 transcription and MIF loss or inhibition reduces Arg1 significantly but more modestly than with individual SCCVII co-culture or IL-4 ( Figure 4A and B) . Lastly, CD206 expression in RAW 264.7 macrophages is predominantly induced by IL-4 alone with little to no induction observed with SCCVII co-culture and MIF loss or inhibition increases CD206 as observed previously ( Figures 1E, 2E and 3E).
BMDMs require both tumor-and macrophage-derived MIF for maximal SCCVII-mediated alternative activation
We next investigated the relative capability of OSCC cells to induce macrophage activation/M2 polarization in primary murine macrophages and whether MIF is necessary. To accomplish this, we utilized BMDMs isolated and differentiated from MIF þ/þ and MIF À/À C57Bl/6 mice 7,24 and co-cultured them with vehicle or . ns, non-significant: P > 0.05; *P 0.05; **P 0.01; ***P 0.001; ****P 0.000.1. Figure 5A , MIF-deficient BMDMs were very resistant to SCCVII-induced Arg1 transcription but exhibited only nominal reductions in the modest induction of VEGF-A ( Figure 5B ). Unlike RAW 264.7 cells, BMDMs exhibited CD206 expression induced by SCCVII cells and a modest reduction was observed in MIF-deficient BMDMs ( Figure 5C ). Interestingly, and unlike our observations with the SCCVII co-cultured RAW 264.7 macrophage cell line, inhibition of SCCVII-cell MIF with 4-IPP resulted in a substantial reduction in SCCVII-induced Arg1 and VEGF-A. Lastly, please note that iNOS and Cox-2 mRNA expression levels were below the level of detection in both treated and untreated primary BMDMs (data not shown).
4-IPP-treated SCCVII cells. As shown in
IL-4 and SCCVII cells cooperate to induce alternative activation in BMDM
We next tested whether combination IL-4 and SCCVII co-culture induces alternative activation in BMDMs as we observed with the RAW 264.7 macrophage cell line ( Figure 4 ). As shown in Figure 6A (C) COX-2; (D) iNOS; (E) CD206. RQ, relative quantity (relative to the reference sample treated with vehicle control DMSO). ns, non-significant: P > 0.05; *P 0.05; **P 0.01; ***P 0.001; ****P 0.000. 1. higher with SCCVII co-culture alone than with IL-4 alone; the opposite of that observed with Arg1 induction (Figures 6A  and 7) . Interestingly, loss of MIF in BMDMs had no effect on either IL-4 treatment, SCCVII co-culture or a combination of the two which is different than the apparent repressive effect of MIF on CD206 expression in RAW 264.7 macrophages ( Figures  1E, 2E , 3E, 4C and D).
Discussion
OSCC disease progression and 5-year survival was recently shown to be predicted by the relative numbers of peritumoral and/or intratumoral TAMs. 25 Our studies now indicate that the murine OSCC cell line SCCVII is sufficient to promote modest macrophage alternative activation (as assessed by Arg1 and CD206 expression 16, 26 alone but its effect can be significantly enhanced in the presence of the Th2 cytokine, IL-4). Moreover, macrophage-derived MIF appears to be necessary for both maximal IL-4 and SCCVII-induced macrophage M2 polarization although its relative requirements appear to be greater for SCCVII-mediated alternative activation than for IL-4 alone and combination IL-4/SCCVII. Prior studies from this laboratory revealed that stromal MIFdeficient mice implanted with high MIF expressing/secreting melanoma cell lines exhibit significantly reduced subcutaneous and metastatic melanoma growth and progression. These reductions coincide with a striking difference in the polarization profiles of TAMs isolated from MIF À/À mice (M1-low Arg1; high TNF-a) vs. those isolated from MIF þ/þ mice (M2-high Arg1; low TNF-a). 7 Importantly, MIF-deficient and 4-IPP-treated MIF
TAMs and myeloid-derived suppressor cells (MDSCs) exhibit significant reductions in T-cell suppressive activities 7, 24 indicating that monocyte/macrophage-derived MIF is necessary for maximal M2 TAM/MDSC immunosuppressive functions. Given the fact that MIF is a cytokine that exerts its activity in an outside-in manner these findings were somewhat surprising in light of the fact that intratumoral MIF levels would be expected to be very high. 7 However these findings were similar to an earlier study reporting that B16F10 melanoma-derived MIF was dispensable for maximal tumor growth while stromal MIF was necessary. 27 That being said, tumor cell-derived, paracrine-acting MIF promotes pro-angiogenic macrophage activation 22 as well as MDSC differentiation 21 suggesting that extracellular MIF is both capable of, and sufficient, to promote innate immune cell immunosuppression. A central goal of this study was to rigorously investigate whether macrophage-derived or tumor-derived MIF is dominant in mediating TAM M2 polarization. Although these studies do, in fact, demonstrate a central and dominant requirement for macrophage-derived MIF in IL-4 and SCCVII-induced M2 polarization in both RAW 264.7 cells and primary BMDMs, the relative contribution of SCCVII MIF is dependent on whether . ns, non-significant: P > 0.05; *P 0.05; **P 0.01; ***P 0.001; ****P 0.000.1.
they are co-cultured with primary macrophages (BMDMssensitive) vs. a macrophage cell line (RAW 264.7-resistant).
The most obvious explanation for this is that the immortalized macrophage cell line has considerably higher MIF expression/ secretion than primary macrophages (data not shown) and, therefore, already possesses sufficient MIF activating contributions from autocrine sources. However, if that were the case, one would also anticipate that tumor-derived MIF would be able to rescue at least some M2 polarization in the MIF À/À , 4-IPPtreated and MIF shRNA macrophages which does not appear to occur. As such, more studies are needed to fully delineate these observed differences in extracellular MIF requirements for macrophage alternative activation.
The rationale behind the initial focus on arginase-1, VEGF-A and CD206 mRNA assessments stemmed primarily from the fact that these markers are very well-characterized macrophage M2/alternative activation functional determinants 16, 17, 23 and because our prior studies revealed that MIF is especially important in driving the maximal expression of these gene products in murine melanoma TAMs. 7 We also chose to investigate the relative expression of more pro-inflammatory mediators such as Cox-2 and iNOS-which can be considered either M1 or M2-associated gene products 18, 28 -because OSCC TAMs reportedly exhibit inflammatory phenotypes. 13, 14 Consistent with this, we have identified that SCCVII tumor cell co-culture promotes a modest induction of iNOS and Cox-2 in RAW 264.7 macrophages. Interestingly, although MIF has been shown to positively regulate the expression of these mediators in a variety of pro-inflammatory disease and activation states, 29, 30 it was found to negatively regulate their expression in melanoma TAMs. 7 However, these ex vivo studies clearly indicate that macrophage-derived MIF is necessary for both iNOS and Cox-2 expression in RAW 264.7 cells co-cultured with SCCVII (Figures 1 and 2 ). In contrast, neither IL-4 nor SCCVII co-culture exhibited any induction of these gene products in primary BMDMs suggesting that this mixed M1/M2 co-culture phenotype is unique to the RAW 264.7 cell line. Our prior in vivo study evaluating loss of stromal MIF in melanoma growth and progression revealed that the small molecule MIF suicide antagonist, 4-IPP, 19 fully phenocopies and recapitulates MIF deficiency in melanoma TAMs. 7 The in vitro studies presented here validate those findings and provide . ns, non-significant: P > 0.05; *P 0.05; **P 0.01; ***P 0.001; ****P 0.000.1. ). ns, non-significant: P > 0.05; *P 0.05; **P 0.01; ***P 0.001; ****P 0.000.1. ). ns, non-significant: P > 0.05; *P 0.05; **P 0.01; ***P 0.001; ****P 0.000. 1. further evidence that 4-IPP is a selective, non-toxic MIF inhibitor that very efficiently phenocopies MIF-deficient phenotypes. Although we are currently evaluating the relative efficacy of other small-molecule MIF inhibitors and neutralizing MIF monoclonal antibodies vs. 4-IPP in OSCC-induced macrophage polarization, we do not anticipate a dominant phenotype with mAbs or compounds (i.e. ISO-1 32 ) that act by disrupting MIF: CD74 receptor interactions which do not appear to be involved in these phenotypes. 7 Given the lack of a dominant phenotype associated with extracellular MIF, an argument could certainly be made that intracellular MIF is mediating the observed MIFdependent contributions to M2 polarization. This would not exclude extracellular MIF from contributing to this effect since internalized MIF has been shown to regulate the function of the intracellular MIF effector, CSN5/Jab1. 31 This is also consistent with the fact that 4-IPP-despite phenocopying, almost exactly, MIF-deficiency-reportedly does not inhibit MIF's binding to its cognate cell surface receptor, CD74. 32 Studies are currently underway to investigate whether, and if so how, MIF contributes to tumor cell and Th2 cytokine-induced macrophage alternative activation in a CSN5-dependent manner. Additionally, it will be very informative to investigate whether, and if so how, 4-IPP disrupts MIF/CSN5-mediated effects in order to design new-and optimize existing-small molecule MIF inhibitors that disrupt tumor-associated immune evasion. An alternative explanation for the effects observed in these studies is that either tumor-derived or monocyte-derived MIF could be posttranslationally modified and/or packaged and delivered by exosomes 20 in such a way as to be specific for monocyte/ macrophage-dependent effects-a possibility that we and others are currently investigating. Regardless, 4-IPP's effects appear to be clinically relevant given that it strongly disrupts MIFdependent human MDSC 24, 33 and human TAM differentiation/ immune suppressive activities. 34 In conclusion, we present novel evidence here that the OSCC murine cell line, SCCVII, functionally induces an M2 macrophage polarization phenotype and that macrophage-derived MIF is necessary for maximal alternative activation. We also present evidence that MIF is important for IL-4-induced macrophage alternative activation and that IL-4 significantly increases SCCVII-induced M2 polarization above IL-4 treatment alone. Combined, these studies provide additional evidence that macrophage MIF is functionally necessary for maximal M2 macrophage polarization induced by tumors and Th2 cytokines and may represent a novel immunotherapuetic target for future clinical use.
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